<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>作為您在 Google 上的首選新聞來源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>石四藥集團（LJUIF,2005.HK），一家中國製藥製造商，週五報告稱 2025 財年的利潤下降，收入疲軟。該公司還宣佈削減股息。</p>
<p>在香港，股票交易價格為每股 2.420 港元，上漲 1.26%。</p>
<p>在 2025 財年，歸屬於公司股東的淨利潤為 4.7064 億港元，比去年的 10.6 億港元下降 55.6%。</p>
<p>每股收益為 0.1605 港元，而去年為 0.3581 港元。</p>
<p>收入約為 41.7 億港元，比去年 57.7 億港元下降 27.8%。</p>
<p>以人民幣計算，公司實現收入約為 38.1 億元人民幣，同比下降 27.6%。</p>
<p>此外，董事會建議每股派發最終股息 0.03 港元，低於去年的 0.095 港元，將於 6 月 4 日支付給在 5 月 21 日登記的股東。</p>
<p>全年總股息為每股 0.08 港元，同比下降 54.3%。</p>
<p>有關更多盈利新聞、盈利日曆和股票盈利信息，請訪問 rttnews.com。</p>
<p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
<p>商業新聞</p>

石四藥集團

<p>石四藥集團報告稱，2025 財年的利潤大幅下降，淨利潤下降 55.6%，降至 4.7064 億港元，原因是收入疲軟，約為 41.7 億港元，同比下降 27.8%。公司宣佈將最終股息削減至每股 0.03 港元，低於 0.095 港元，導致年度總股息降至 0.08 港元，減少 54.3%。股價交易在 2.420 港元，上漲 1.26%</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>作為您在 Google 上的首選新聞來源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>SSY Group Ltd., (LJUIF,2005.HK), a Chinese pharmaceutical manufacturer, reported Friday lower profit in fiscal 2025 with weak revenues. The company also announced a cut in dividend.</p>
<div class="lb-trans"><p>石四藥集團（LJUIF,2005.HK），一家中國製藥製造商，週五報告稱 2025 財年的利潤下降，收入疲軟。該公司還宣佈削減股息。</p>
</div><p>In Hong Kong, the shares were trading at HK$2.420, up 1.26 percent.</p>
<div class="lb-trans"><p>在香港，股票交易價格為每股 2.420 港元，上漲 1.26%。</p>
</div><p>In fiscal 2025, net profit attributable to Equity shareholders of the Company HK$470.64 million, down 55.6 percent from HK$1.06 billion.</p>
<div class="lb-trans"><p>在 2025 財年，歸屬於公司股東的淨利潤為 4.7064 億港元，比去年的 10.6 億港元下降 55.6%。</p>
</div><p>Earnings per share were HK$0.1605, compared to prior year's HK$0.3581.</p>
<div class="lb-trans"><p>每股收益為 0.1605 港元，而去年為 0.3581 港元。</p>
</div><p>Revenue was approximately HK$4.17 billion, decrease of 27.8 percent from HK$5.77 billion a year ago.</p>
<div class="lb-trans"><p>收入約為 41.7 億港元，比去年 57.7 億港元下降 27.8%。</p>
</div><p>In terms of Renminbi, the company achieved a revenue of around RMB3.81 billion, representing a decrease of 27.6 percent as compared to last year.</p>
<div class="lb-trans"><p>以人民幣計算，公司實現收入約為 38.1 億元人民幣，同比下降 27.6%。</p>
</div><p>Further, the Board recommended a final dividend of HK$0.03 per share, down from HK$0.095 per share last year, payable on June 4 to the shareholders in the register of members on May 21.</p>
<div class="lb-trans"><p>此外，董事會建議每股派發最終股息 0.03 港元，低於去年的 0.095 港元，將於 6 月 4 日支付給在 5 月 21 日登記的股東。</p>
</div><p>Total dividend for the year was HK$0.08 per share, representing a decrease of 54.3 percent as compared to last year.</p>
<div class="lb-trans"><p>全年總股息為每股 0.08 港元，同比下降 54.3%。</p>
</div><p>For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.</p>
<div class="lb-trans"><p>有關更多盈利新聞、盈利日曆和股票盈利信息，請訪問 rttnews.com。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如有意見和反饋，請聯繫：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商業新聞</p>
</div>

石四藥集團 2025 財年利潤因收入疲軟而下降；削減股息 - 最新消息